Gsk Plc

Gsk (GSK)

Buy
Sell
Company name:Gsk Plc
Company Description:A group engaged in the creation; discovery; development; manufacture and marketing of pharmaceutical and consumer health-related products
EPIC:GSKTrading Currency:GBX
Market Sector:FE10ISIN:GB0009252882
Market Segment:SET1Share Type:DE
WWW Address:http://www.gsk.com/Description:ORD 25P
Industry Sector:PHARMACEUTICALS & BIOTECHNOLOGY
 Price Price Change [%] Bid Offer Open High Low Volume
 1,799.00 images.advfn.com/imagesnew/2/gb/up 13.4 [0.75] 1,798.80 1,799.00 1,792.20 1,812.40 1,789.80 8,211,216
 Market Cap. [m] Shares In Issue [m] Beta EPS DPS PE Ratio Yield 52-Wks-Range
 91,460.70 5,083.97 0.07 87.60 80.00 20.54 4.45 1,817.00 - 1,362.80

Gsk Key Figures

(at previous day's close)
Market Cap.91,460.70m
Shares In Issue5,083.97m
Prev. Close1,785.60
PE Ratio20.54 
Dividend Yield4.45%
EPS - basic87.60p
Dividend PS80.00p
Dividend Cover1.10 
Cash Flow PS156.41p
Return On Equity (ROE)29.13%
Operating Margin15.95%
PEG Factor-0.85 
EPS Growth Rate-24.16%
Dividends PS Growth Rate-%
Net Debt53,487.00m
Gross Gearing73.02%
Quick Assets17,860.00m
Net Working Capital-27.00m
Intangibles / Fixed Assets73.26%
Turnover PS671.01p
Pre-Tax Profit PS107.04p
Retained Profit PS7.59p
Cash PS84.07p
Net Cash PS-381.51p
Net Tangible Asset Value PS *-503.07p
Net Asset Value PS419.79p
Spread0.20 (0.01%) 

Gsk Balance Sheet

L^GSK:Liabilities+EQL^GSK:Assets

Share Price Performance

Sample Period HighLow
1 week1,812.401,747.80
4 weeks1,812.401,666.00
12 weeks1,817.001,666.00
1 year1,817.001,362.80

Share Price Chart (5 years)

Gsk Historic Returns

Period OpenChange%Open Avg.Avg. Daily Vol [m]Total Vol [m]VWAP
1 week1,758.0041.002.331,747.808.881,772.80
4 weeks1,722.0077.004.471,666.0012.091,724.49
12 weeks1,771.0028.001.581,666.0011.901,748.05
26 weeks1,590.60208.4013.101,445.4010.541,680.69
1 year1,441.60357.4024.791,362.808.861,600.46
3 years1,637.80161.209.841,190.809.181,551.21
5 years1,624.00175.0010.781,190.809.141,521.36

Gsk Key Management Ratios

Gsk Investment Ratios

(Market value analysis) at previous day's close
PQ Ratio35.93 
PE Ratio20.54 
Tobin's Q Ratio 1.15 
Tobin's Q Ratio (excl. intangibles)2.33 
Dividend Yield4.45%
Market-to-Book Ratio6.08 
Price-to-Pre-Tax Profit PS16.81 
Price-to-Retained Profit PS236.94 
Price-to-Cash Flow PS11.50 
Price-to-Sales PS2.68 
Price-to-Net Tangible Asset Value PS-4.74 
Price-to-Cash PS21.40 
Net Working Capital PS-0.53 
Price Pct to Working Capital PS-3,387.51%
Earnings Yield4.87%
Average PE22.25 
Years in average5 
PE to PE average92.29%

Gsk Financial Ratios

(Leverage Ratios)
Debt Ratio61.50%
Debt-to-Equity Ratio1.60 
Debt-to-Equity Ratio (excl. Intgbl)-1.77 
Debt-to-Equity Market Value0.37 
Net Gearing67.62%
Net Gearing (excl. Intangibles)139.03%
Gross Gearing73.02%
Gross Gearing (excl. Intangibles)150.14%
Gearing Under 1 Year29.92%
Gearing Under 1 Year (excl. Intgbl)61.53%
Assets/Equity3.71 
Cash/Equity20.03 
(Liquidity Ratios)
Net Working Capital to Total Assets-0.03%
Current Ratio1.00 
Quick Ratio (Acid Test)0.75 
Liquidity Ratio0.18 
Cash & Equiv/Current Assets18.08%
(Solvency Ratios)
Enterprise Value127,564.70m
CFO/Sales0.23 
CFO/Attributable Profit1.81 
CFO/Assets0.10 
CFO/Debt0.14 
Total Debt/Equity Market Value0.63 
Total Debt/Sales1.69 
Total Debt/Pre-Tax Profit10.61 
Total Debt57,761.00m
Total Debt/Net Current Assets-2,139.34%
(Dodds - Graham Ratios)
3 yr Compound Earnings Growth-%
5 yr Compound Earnings Growth22.78%
10 yr Compound Earnings Growth-%
Earn drops > 5% in 10yrs10 
Beta (60-Mnth)Beta (36-Mnth)
0.06900.1236

Gsk Operating Ratios

(Profitability Ratios)
Return On Capital Employed (ROCE)9.82%
Return On Assets (ROA)5.50%
Net Profit Margin12.85%
Assets Turnover0.43 
Return On Equity (ROE)29.13%
Return On Investment (ROI)7.71%
Dividend Payout Ratio91.32%
Plowback Ratio8.68%
Growth from Plowback Ratio2.57%
Net Income Of Revenues1.13%
(Asset Utilisation Multiples)
Shareholders Equity Turnover2.30 
Fixed Assets Turnover0.61 
Current Assets Turnover1.42 
Net Working Capital Turnover 
Inventory Turnover5.79 
(Other Operating Ratios)
Total Assets-to-Sales2.34 
Debtors-to-Sales37.34%
Debt Collection Period136.28Days

Gsk Dividends

Announcement DateTypeCurr.Dividend AmountPeriod StartPeriod EndEx DateRecord DatePayment DateTotal Dividend Amount
27 Apr 2022QuarterlyGBX14.0031/12/202131/12/202219/05/202220/05/202201/07/2022-
09 Feb 2022FinalGBX23.0031/12/202031/12/202124/02/202225/02/202207/04/202280.00
27 Oct 2021QuarterlyGBX19.0031/12/202031/12/202118/11/202119/11/202113/01/2022-
28 Jul 2021QuarterlyGBX19.0031/12/202031/12/202119/08/202120/08/202107/10/2021-
28 Apr 2021QuarterlyGBX19.0031/12/202031/12/202120/05/202121/05/202108/07/2021-
03 Feb 2021FinalGBX23.0031/12/201931/12/202018/02/202119/02/202108/04/202180.00
28 Oct 2020QuarterlyGBX19.0031/12/201931/12/202012/11/202013/11/202014/01/2021-
29 Jul 2020QuarterlyGBX19.0031/12/201931/12/202013/08/202014/08/202008/10/2020-
29 Apr 2020QuarterlyGBX19.0031/12/201931/12/202014/05/202015/05/202009/07/2020-
05 Feb 2020FinalGBX23.0031/12/201831/12/201920/02/202021/02/202009/04/202080.00
30 Oct 2019QuarterlyGBX19.0031/12/201831/12/201914/11/201915/11/201909/01/2020-
24 Jul 2019QuarterlyGBX19.0031/12/201831/12/201908/08/201909/08/201910/10/2019-
01 May 2019QuarterlyGBX19.0031/12/201831/12/201916/05/201917/05/201911/07/2019-
06 Feb 2019FinalGBX23.0031/12/201731/12/201821/02/201922/02/201911/04/201980.00
31 Oct 2018QuarterlyGBX19.0031/12/201731/12/201815/11/201816/11/201810/01/2019-
25 Jul 2018QuarterlyGBX19.0031/12/201731/12/201809/08/201810/08/201811/10/2018-
25 Apr 2018QuarterlyGBX19.0031/12/201731/12/201810/05/201811/05/201812/07/2018-
07 Feb 2018FinalGBX23.0031/12/201631/12/201722/02/201823/02/201812/04/201880.00
25 Oct 2017QuarterlyGBX19.0031/12/201631/12/201709/11/201710/11/201711/01/2018-
26 Jul 2017QuarterlyGBX19.0031/12/201631/12/201710/08/201711/08/201712/10/2017-
26 Apr 2017QuarterlyGBX19.0031/12/201631/12/201711/05/201712/05/201713/07/2017-
08 Feb 2017FinalGBX23.0031/12/201531/12/201623/02/201724/02/201713/04/201780.00
26 Oct 2016QuarterlyGBX19.0031/12/201531/12/201603/11/201604/11/201612/01/2017-
27 Jul 2016QuarterlyGBX19.0031/12/201531/12/201611/08/201612/08/201613/10/2016-
27 Apr 2016QuarterlyGBX19.0031/12/201531/12/201612/05/201613/05/201614/07/2016-
03 Feb 2016SpecialGBX20.0031/12/201431/12/201518/02/201619/02/201614/04/2016-
03 Feb 2016FinalGBX23.0031/12/201431/12/201518/02/201619/02/201614/04/2016100.00
19 Oct 2015QuarterlyGBX19.0031/12/201431/12/201512/11/201513/11/201514/01/2016-
29 Jul 2015QuarterlyGBX19.0031/12/201431/12/201513/08/201514/08/201501/10/2015-
06 May 2015QuarterlyGBX19.0031/12/201431/12/201514/05/201515/05/201509/07/2015-
04 Feb 2015FinalGBX23.0031/12/201331/12/201419/02/201520/02/201509/04/201580.00
22 Oct 2014QuarterlyGBX19.0031/12/201331/12/201406/11/201407/11/201408/01/2015-
24 Jul 2014QuarterlyGBX19.0031/12/201331/12/201406/08/201408/08/201402/10/2014-
30 Apr 2014QuarterlyGBX19.0031/12/201331/12/201414/05/201416/05/201410/07/2014-
05 Feb 2014FinalGBX23.0031/12/201231/12/201319/02/201421/02/201410/04/201478.00
23 Oct 2013QuarterlyGBX19.0031/12/201231/12/201313/11/201315/11/201309/01/2014-
24 Jul 2013QuarterlyGBX18.0031/12/201231/12/201307/08/201309/08/201303/10/2013-
24 Apr 2013QuarterlyGBX18.0031/12/201231/12/201308/05/201310/05/201311/07/2013-
06 Feb 2013FinalGBX22.0031/12/201131/12/201220/02/201322/02/201311/04/201374.00
31 Oct 2012QuarterlyGBX18.0031/12/201131/12/201214/11/201216/11/201203/01/2013-
25 Jul 2012QuarterlyGBX17.0031/12/201131/12/201208/08/201210/08/201204/10/2012-
25 Apr 2012QuarterlyGBX17.0031/12/201131/12/201209/05/201211/05/201205/07/2012-
07 Feb 2012SpecialGBX5.0031/12/201031/12/201115/02/201217/02/201212/04/2012-
07 Feb 2012FinalGBX21.0031/12/201031/12/201115/02/201217/02/201212/04/201275.00
26 Oct 2011InterimGBX17.0031/12/201031/12/201102/11/201104/11/201105/01/2012-
26 Jul 2011InterimGBX16.0031/12/201031/12/201103/08/201105/08/201106/10/2011-
27 Apr 2011InterimGBX16.0031/12/201031/12/201104/05/201106/05/201107/07/2011-
03 Feb 2011FinalGBX19.0031/12/200931/12/201009/02/201111/02/201107/04/201165.00
21 Oct 2010InterimGBX16.0031/12/200931/12/201027/10/201029/10/201006/01/2011-
21 Jul 2010InterimGBX15.0031/12/200931/12/201028/07/201030/07/201007/10/2010-
28 Apr 2010InterimGBX15.0031/12/200931/12/201005/05/201007/05/201008/07/2010-
04 Feb 2010FinalGBX18.0031/12/200831/12/200910/02/201012/02/201008/04/201061.00
29 Oct 2009QuarterlyGBX15.0031/12/200831/12/200904/11/200906/09/200907/01/2010-
30 Jul 2009QuarterlyGBX14.0031/12/200831/12/200931/07/200931/07/200908/10/200928.00
22 Apr 2009QuarterlyGBX14.0031/12/200831/12/200929/04/200901/05/200909/07/2009-
05 Feb 2009FinalGBX17.0031/12/200731/12/200811/02/200913/02/200909/04/200957.00
22 Oct 2008QuarterlyGBX14.0031/12/200731/12/200829/10/200831/10/200809/01/2008-
07 Feb 2008FinalGBX13.0031/12/200631/12/200713/02/200815/02/200810/04/200853.00
25 Jul 2007QuarterlyGBX12.0031/12/200631/12/200701/08/200703/08/200711/10/2007-
24 Apr 2007QuarterlyGBX12.0031/12/200631/12/200702/05/200704/05/200712/07/2007-
08 Feb 2007FinalGBX-31/12/200531/12/2006---48.00
08 Feb 2007QuarterlyGBX14.0031/12/200531/12/200614/02/200616/02/200612/04/2007-
26 Oct 2006QuarterlyGBX12.0031/12/200531/12/200601/11/200603/11/200604/01/2007-
26 Jul 2006QuarterlyGBX11.0031/12/200531/12/200602/08/200604/08/200605/10/2006-
27 Apr 2006QuarterlyGBX11.0031/12/200531/12/200610/05/200612/05/200606/07/2006-
08 Feb 2006FinalGBX14.0031/12/200431/12/200515/02/200617/02/200606/04/200644.00
27 Oct 2005QuarterlyGBX10.0031/12/200431/12/200502/11/200504/11/200505/01/2006-
29 Jul 2005QuarterlyGBX10.0031/12/200431/12/200503/08/200505/08/200506/10/2005-
28 Apr 2005QuarterlyGBX10.0031/12/200431/12/200511/05/200513/05/200507/07/2005-
10 Feb 2005FinalGBX12.0031/12/200331/12/200416/02/200518/02/200507/04/200542.00
28 Oct 2004QuarterlyGBX10.0031/12/200331/12/200403/11/200405/11/200406/01/2005-
27 Jul 2004QuarterlyGBX10.0031/12/200331/12/200412/05/200414/05/200401/07/2004-
27 Jul 2004QuarterlyGBX10.0031/12/200331/12/200404/08/200406/08/200430/09/2004-
12 Feb 2004FinalGBX14.0031/12/200231/12/200318/02/200420/02/200415/04/200441.00
11 Feb 2004QuarterlyGBX9.0031/12/200231/12/200329/10/200331/10/200306/01/2004-
23 Jul 2003QuarterlyGBX9.0031/12/200231/12/200330/07/200301/08/200302/10/2003-
30 Apr 2003QuarterlyGBX9.0031/12/200231/12/200307/05/200309/05/200303/07/2003-
12 Feb 2003FinalGBX13.0031/12/200131/12/200219/02/200321/02/200317/04/200340.00
23 Oct 2002QuarterlyGBX9.0030/03/200230/09/200230/10/200201/11/200203/01/2003-
24 Jul 2002QuarterlyGBX9.0030/12/200130/06/200231/07/200202/08/200203/10/2002-
25 Apr 2002QuarterlyGBX9.0001/10/200131/03/200201/05/200203/05/200204/07/2002-
14 Feb 2002FinalGBX12.0031/12/200031/12/200120/02/200222/02/200218/04/200239.00
23 Oct 2001QuarterlyGBX9.0030/09/200030/09/200131/10/200102/11/200103/01/2002-
24 Jul 2001QuarterlyGBX9.0030/06/200030/06/200101/08/200103/08/200104/10/2001-
24 Apr 2001QuarterlyGBX9.0031/03/200031/03/200102/05/200104/05/200105/07/2001-
13 Dec 2000FinalGBX23.0031/12/199931/12/200018/12/200022/12/200017/04/200138.00
27 Jul 2000InterimGBX15.0030/12/199930/06/200007/08/200011/08/200016/10/2000-
16 Feb 2000FinalGBX22.0031/12/199831/12/199928/02/200003/03/200025/05/200037.00
29 Jul 1999InterimGBX15.0030/12/199830/06/199909/08/199913/08/199901/10/1999-
18 Feb 1999FinalGBX21.0031/12/199731/12/199801/03/199905/03/199920/05/199936.00

Gsk Fundamentals

 31 Dec 2018 (GBP)31 Dec 2019 (GBP)31 Dec 2020 (GBP)31 Dec 2021 (GBP)
turnover30,821.00100.00%33,754.00100.00%34,099.00100.00%34,114.00100.00%m
pre tax profit4,048.0013.13%6,221.0018.43%6,968.0020.43%5,442.0015.95%m
attributable profit3,623.0011.75%4,645.0013.76%5,749.0016.86%4,385.0012.85%m
retained profit-304.00-0.99%692.002.05%1,772.005.20%386.001.13%m
eps - basic (p)73.70 93.90 115.50 87.60 
eps - diluted (p)72.90 93.90 114.10 86.60 
dividends per share80.00 80.00 80.00 80.00 

Gsk Balance Sheet

 31 Dec 2018 (GBP)31 Dec 2019 (GBP)31 Dec 2020 (GBP)31 Dec 2021 (GBP)
L^GSK:Liabilities+EQL^GSK:AssetsL^GSK:Liabilities+EQL^GSK:AssetsL^GSK:Liabilities+EQL^GSK:AssetsL^GSK:Liabilities+EQL^GSK:Assets
 31 Dec 2018 (GBP)31 Dec 2019 (GBP)31 Dec 2020 (GBP)31 Dec 2021 (GBP)
ASSETS
fixed assets fixed assets11,058.0019.04%10,348.0012.98%11,006.0013.68%10,672.0013.49%m
intangibles intangibles22,991.0039.59%42,483.0053.31%40,421.0050.26%40,631.0051.36%m
fixed investments fixed investments3,475.005.98%3,774.004.74%4,700.005.84%4,157.005.26%m
current assets - other current assets - other653.001.12%873.001.10%106.000.13%22.000.03%m
stocks stocks5,476.009.43%5,947.007.46%5,996.007.45%5,783.007.31%m
debtors debtors10,539.0018.15%11,560.0014.51%11,910.0014.81%13,564.0017.15%m
cash & securities cash & securities3,874.006.67%4,707.005.91%6,292.007.82%4,274.005.40%m
TOTAL58,066.00100%79,692.00100%80,431.00100%79,103.00100%m
LIABILITIES
creditors - short creditors - short22,491.0038.73%24,050.0030.18%22,148.0027.54%23,670.0029.92%m
creditors - long creditors - long31,903.0054.94%37,285.0046.79%37,475.0046.59%34,091.0043.10%m
creditors - other creditors - other--%--%--%--%m
subordinated loans subordinated loans--%--%--%--%m
insurance funds insurance funds--%--%--%--%m
TOTAL54,394.0093.68%61,335.0076.97%59,623.0074.13%57,761.0073.02%m
EQUITY
ord cap, reserves ord cap, reserves4,360.007.51%11,984.0015.04%14,587.0018.14%15,055.0019.03%m
prefs, minorities prefs, minorities-688.00-1.18%6,373.008.00%6,221.007.73%6,287.007.95%m
TOTAL3,672.006.32%18,357.0023.03%20,808.0025.87%21,342.0026.98%m
OTHER
NAV Basic- - - - 
NAV Diluted- - - - 

Gsk Cash Flow Statement

31 Dec 2018 (GBP)31 Dec 2019 (GBP)31 Dec 2020 (GBP)31 Dec 2021 (GBP)
Operating CF8,421.008,020.008,441.007,952.00m
Pre-Financing CF6,868.002,666.0010,602.006,175.00m
Retained CF479.00826.00470.00-1,414.00m

Gsk Brokers

NameActivityTypeMnemonicCode
Evolution Securities LimitedMarket Maker(MME)Broker/DealerEVOEVBGGB21MMT
Winterflood Securities LtdMarket Maker(MME)Broker/DealerWINSWNTSGB2LBIC
ADVFN Advertorial
Your Recent History
LSE
GSK
Gsk
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20220704 15:07:11